Glucose-dependent Insulinotropic Peptide Glucose-dependent Insulinotropic Peptide (GIP) is a 42-amino acid peptide hormone produced by K cells located primarily in the proximal small intestine (44)
The pharmacist and the patient make a shared decision to adjust the insulin glargine to 20 units daily to move the patients glycemic control closer to goal
Efficacy and safety profile of exenatide once weekly compared with insulin once daily in Japanese patients with type 2 diabetes treated with oral antidiabetes drug(s): results from a 26-week, randomized, open-label, parallel-group, multicenter, noninferiority study
Medically-supervised weight loss injections, when combined with diet and exercise, can assist with weight loss.
Ask specifically how the practice handles GLP-1s at scheduling, since the answer varies practice to practice
A systematic review and meta-analysis of diet-induced weight loss interventions in overweight or obese individuals with KOA found that weight loss, especially when combined with exercise, was associated with improvements in pain and function ( 4.2 GLP-1 therapy should complement, not replace, exercise-based rehabilitation Importantly, repositioning anti-obesity pharmacotherapy earlier in the pathway should not be interpreted as downgrading exercise therapy
![Homeward Path [Commander 2011] Phyrexian Angel Horror](https://cdn.shopify.com/s/files/1/0578/2503/4408/products/b8b39f19-b091-5044-9e37-a7d0f0864e49_8630057b-989b-4268-bff5-8a5fd54eb4d6.jpg?v=1699582204)
